Adverum Biotechnologies General and Administrative Expenses 2011-2026 | ADVM

General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.

What these expenses include

Salaries of administrative staff (executives, HR, accountants, legal personnel)
Office rent and utilities
Office equipment and IT infrastructure
Professional services (auditors, lawyers, consultants)
Insurance
General administrative travel and representation expenses

What the metric indicates

Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure
Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit
Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry
Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines

Annual General and Administrative Expenses Adverum Biotechnologies

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
63.1 M	55.1 M	57.9 M	64.4 M	44.6 M	28.4 M	24.6 M	20.9 M	24.4 M	22.1 M	8 M	1.78 M	536 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
64.4 M	536 K	32 M

Quarterly General and Administrative Expenses Adverum Biotechnologies

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
9.11 M	12.7 M	19.5 M	15 M	15.8 M	13.8 M	13.8 M	12.5 M	12.8 M	-	17.2 M	13.8 M	15.2 M	-	14.5 M	21.9 M	16.2 M	-	11.4 M	10.6 M	9.04 M	-	7.39 M	7.13 M	5.58 M	-	4.83 M	9.18 M	5.37 M	-	4.76 M	4.06 M	7.99 M	-	6.15 M	5.11 M	8.32 M	-	7.63 M	4.96 M	4.14 M	-	2.4 M	1.49 M	726 K	-	258 K	194 K	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
21.9 M	194 K	9.27 M

General and Administrative Expenses of other stocks in the Biotechnology industry

Issuer	General and Administrative Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	78.3 M	-	2.43 %	$ 254 M	Germany
Alector ALEC	54 M	$ 2.08	-14.4 %	$ 214 M	USA
Acer Therapeutics ACER	12.7 M	-	2.71 %	$ 14 M	USA
Altimmune ALT	21 M	$ 4.2	-2.67 %	$ 298 M	USA
Apellis Pharmaceuticals APLS	550 M	$ 20.24	-3.44 %	$ 2.55 B	USA
Aptorum Group Limited APM	5.41 M	$ 0.8	1.87 %	$ 4.36 M	China
Aprea Therapeutics APRE	8.43 M	$ 0.88	-3.72 %	$ 3.18 M	USA
Aptevo Therapeutics APVO	10.2 M	$ 7.2	-1.64 %	$ 1.99 M	USA
I-Mab IMAB	900 M	-	-	$ 866 M	China
Aquestive Therapeutics AQST	50.2 M	$ 4.1	2.37 %	$ 356 M	USA
Alexion Pharmaceuticals, Inc. ALXN	1.4 B	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	9.33 M	-	-10.17 %	$ 12.2 K	USA
Arcturus Therapeutics Holdings ARCT	52.8 M	$ 8.35	1.46 %	$ 225 M	Israel
Ardelyx ARDX	337 M	$ 6.37	-2.75 %	$ 1.54 B	USA
Biophytis SA BPTS	7.15 M	-	-13.47 %	$ 169 M	France
Aeglea BioTherapeutics AGLE	47.9 M	-	-	$ 1.01 B	USA
argenx SE ARGX	308 M	$ 756.71	-1.33 %	$ 25 B	Niderland
Armata Pharmaceuticals ARMP	11.6 M	$ 10.91	1.58 %	$ 394 M	USA
Applied Genetic Technologies Corporation AGTC	17 M	-	-	$ 26.5 M	USA
Arcutis Biotherapeutics ARQT	275 M	$ 25.33	-6.1 %	$ 3.22 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	4.66 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.95 M	-	-18.52 %	$ 27.3 M	Britain
Artelo Biosciences ARTL	5.98 M	$ 1.15	-3.36 %	$ 2.32 M	USA
Arvinas ARVN	95.9 M	$ 12.97	-2.3 %	$ 920 M	USA
Arrowhead Pharmaceuticals ARWR	124 M	$ 61.74	-2.42 %	$ 8.26 B	USA
Ascendis Pharma A/S ASND	160 M	$ 231.56	-0.83 %	$ 5 B	Danmark
Alterity Therapeutics Limited ATHE	5.51 M	$ 3.39	-1.63 %	$ 8.16 B	Australia
Actinium Pharmaceuticals ATNM	12.1 M	$ 1.17	-0.85 %	$ 35.2 M	USA
Atossa Therapeutics ATOS	14 M	$ 4.39	-0.9 %	$ 553 M	USA
Atara Biotherapeutics ATRA	39.9 M	$ 5.01	-7.47 %	$ 37.5 M	USA
Aurinia Pharmaceuticals AUPH	102 M	$ 14.14	-0.21 %	$ 1.9 B	Canada
ARCA biopharma ABIO	13.1 M	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	89.7 M	-	-24.86 %	$ 820 K	USA
Autolus Therapeutics plc AUTL	46.7 M	$ 1.68	-1.75 %	$ 429 M	Britain
Acasti Pharma ACST	7.17 M	-	4.01 %	$ 150 M	Canada
Atea Pharmaceuticals AVIR	48.8 M	$ 4.69	0.21 %	$ 395 M	USA
Институт стволовых клеток человека ISKJ	25.8 M	-	-	-	Russia
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
Anavex Life Sciences Corp. AVXL	13.8 M	$ 4.54	2.44 %	$ 387 M	USA
Akero Therapeutics AKRO	37.9 M	-	-	$ 3.67 B	USA
Akouos AKUS	22.2 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	69.6 M	-	-0.23 %	$ 916 M	USA
Axon Enterprise AXON	741 M	$ 570.5	5.18 %	$ 43.2 B	USA
Axsome Therapeutics AXSM	63.3 M	$ 162.28	-0.98 %	$ 8.07 B	USA
Allena Pharmaceuticals ALNA	12.7 M	-	3.16 %	$ 1.9 M	USA
Aytu BioScience AYTU	17.4 M	$ 2.56	-0.58 %	$ 16.1 M	USA
Aileron Therapeutics ALRN	13.9 M	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	42.9 M	-	4.14 %	$ 49.1 M	USA
Alpine Immune Sciences ALPN	18 M	-	-	$ 2.17 B	USA